Philip W. Gold mostly deals with Internal medicine, Endocrinology, Corticotropin-releasing hormone, Hypothalamus and Depression. His work is connected to Hormone, Corticosterone, Glucocorticoid, Hydrocortisone and Hypothalamic–pituitary–adrenal axis, as a part of Internal medicine. His study connects Arthritis and Endocrinology.
His studies in Corticotropin-releasing hormone integrate themes in fields like Basal, Antagonist, Receptor antagonist, Vasopressin and Peptide hormone. His study in Hypothalamus is interdisciplinary in nature, drawing from both Weight loss, Neuropeptide, Galanin, Chronic stress and Amygdala. His work on Major depressive disorder as part of general Depression research is frequently linked to Category test, bridging the gap between disciplines.
The scientist’s investigation covers issues in Internal medicine, Endocrinology, Corticotropin-releasing hormone, Hormone and Depression. His work in Hypothalamic–pituitary–adrenal axis, Corticosterone, Peptide hormone, Neuropeptide and Basal are all subfields of Internal medicine research. His Endocrinology study frequently draws connections between adjacent fields such as Cerebrospinal fluid.
His biological study spans a wide range of topics, including Agonist, Pituitary gland and Vasopressin. His study on Depression is covered under Psychiatry. He combines subjects such as Receptor and Amygdala with his study of Hypothalamus.
Internal medicine, Endocrinology, Depression, Major depressive disorder and Bipolar disorder are his primary areas of study. His Internal medicine and Adrenocorticotropic hormone, Case-control study, Epinephrine, Cerebrospinal fluid and Endocrine system investigations all form part of his Internal medicine research activities. His research related to Hydrocortisone, Osteoporosis, Glucocorticoid, Body mass index and Glucocorticoid receptor might be considered part of Endocrinology.
His work on Melancholic depression as part of general Depression research is often related to Crossover study, thus linking different fields of science. His research integrates issues of Coagulation, Prospective cohort study, Chronic stress, Hyperinsulinism and Risk factor in his study of Major depressive disorder. He has included themes like Offspring, Antidepressant and Clinical psychology, Mood in his Bipolar disorder study.
His scientific interests lie mostly in Endocrinology, Internal medicine, Depression, Major depressive disorder and Hydrocortisone. His study in Corticosterone, Adrenocorticotropic hormone, Basal, Epinephrine and Plasma concentration are all subfields of Endocrinology. As part of his studies on Internal medicine, Philip W. Gold frequently links adjacent subjects like Anorexia nervosa.
His work carried out in the field of Depression brings together such families of science as Heart failure, Norepinephrine and Mood. He interconnects Body mass index, Prospective cohort study, Osteoporosis and Risk factor in the investigation of issues within Major depressive disorder. The concepts of his Hydrocortisone study are interwoven with issues in Agonist, Ex vivo, Cytokine and Corticotropin-releasing hormone.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The Concepts of Stress and Stress System Disorders: Overview of Physical and Behavioral Homeostasis
George P. Chrousos;Philip W. Gold.
Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states
P W Gold;G P Chrousos.
Molecular Psychiatry (2002)
Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (2)
Philip W. Gold;Frederick K. Goodwin;George P. Chrousos.
The New England Journal of Medicine (1988)
Mood disorders in the medically ill: scientific review and recommendations.
Dwight L. Evans;Dennis S. Charney;Dennis S. Charney;Lydia Lewis;Robert N. Golden.
Biological Psychiatry (2005)
Mechanisms of stress: a dynamic overview of hormonal and behavioral homeostasis.
Elizabeth O. Johnson;Themis C. Kamilaris;George Panagiotis Chrousos;Philip W.P. Gold.
Neuroscience & Biobehavioral Reviews (1992)
Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome.
Mark A. Demitrack;Janet K. Dale;Stephen E. Straus;Louisa Laue.
The Journal of Clinical Endocrinology and Metabolism (1991)
Interactions between the Hypothalamic-Pituitary-Adrenal Axis and the Female Reproductive System: Clinical Implications
George P. Chrousos;David J. Torpy;Philip W. Gold.
Annals of Internal Medicine (1998)
Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats
Esther M. Sternberg;Joanna M. Hill;George P. Chrousos;Themis Kamilaris.
Proceedings of the National Academy of Sciences of the United States of America (1989)
Human leptin levels are pulsatile and inversely related to pituitary-adrenal function.
Julio Licinio;Christos Mantzoros;André B. Negråo;Giovanni Cizza.
Nature Medicine (1997)
Altered expression of hypothalamic neuropeptide mRNAs in food-restricted and food-deprived rats.
Linda S. Brady;Mark A. Smith;Philip W. Gold;Miles Herkenham.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: